The source provides an overview of a groundbreaking study published in Nature Partner Journals' Aging, which suggests that psilocybin, a compound found in psychedelic mushrooms, may possess significant anti-aging properties. Research conducted by Emory University and Baylor College of Medicine found that psilocin, the active metabolite, extended the lifespan of human cells by over 50% and improved survival rates in aged mice by 30%. The episode explains that psilocybin appears to target multiple "hallmarks of aging," such as telomere shortening, oxidative stress, and DNA damage, working through mechanisms like upregulating telomerase and boosting antioxidant pathways. This discovery is framed as a potential shift in the $60 billion global anti-aging industry, repositioning psychedelics from therapeutic mental health treatments to powerful geroprotective agents that enhance systemic cellular resilience.

Ver todos los episodios